[{"indications": "Indications\u00a0see under Dose", "name": "OXPRENOLOL HYDROCHLORIDE Modified release", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "2 Cardiovascular system", "2.4 Beta-adrenoceptor blocking drugs", "OXPRENOLOL HYDROCHLORIDE", "Modified release"], "cautions": "Cautions\u00a0see under Propranolol Hydrochloride", "side-effects": "Side-effects\u00a0see under Propranolol Hydrochloride", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/2511.htm", "doses": ["Hypertension, 80\u2013160\u00a0mg daily in 2\u20133 divided doses, increased\r\nas required; max. 320\u00a0mg daily", "Angina, 80\u2013160\u00a0mg daily in 2\u20133 divided doses; max. 320\u00a0mg daily", "Arrhythmias, 40\u2013240\u00a0mg daily in 2\u20133 divided doses; max. 240\u00a0mg\r\ndaily", "Anxiety symptoms (short-term use), 40\u201380\u00a0mg daily in 1\u20132 divided\r\ndoses", "Name[Slow-Trasicor\u00ae (Amdipharm) ] Tablets, m/r, f/c, oxprenolol\r\nhydrochloride 160\u00a0mg, net price 28-tab pack = \u00a37.50. \r\n    Label:\r\n    8, 25Dose\u00a0hypertension, angina, initially 160\u00a0mg once daily; if\r\nnecessary may be increased to max. 320\u00a0mg daily"], "pregnancy": "Pregnancy\u00a0\n(From 2.4 Beta-adrenoceptor blocking drugs: British National Formulary)\nPregnancy\u00a0Beta-blockers may cause intra-uterine growth restriction, neonatal hypoglycaemia, and bradycardia; the risk is greater in severe hypertension. The use of labetalol in maternal hypertension is not known to be harmful, except possibly in the first trimester. Information on the safety of carvedilol during pregnancy is lacking. If beta-blockers are used close to delivery, infants should be monitored for signs of beta-blockade (and alpha-blockade with labetalol or carvedilol). For the treatment of hypertension in pregnancy, see section 2.5."}, {"indications": "Indications\u00a0see under Dose", "name": "OXPRENOLOL HYDROCHLORIDE With diuretic", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "2 Cardiovascular system", "2.4 Beta-adrenoceptor blocking drugs", "OXPRENOLOL HYDROCHLORIDE", "With diuretic"], "cautions": "Cautions\u00a0see under Propranolol Hydrochloride", "side-effects": "Side-effects\u00a0see under Propranolol Hydrochloride", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/2513.htm", "doses": ["Hypertension, 80\u2013160\u00a0mg daily in 2\u20133 divided doses, increased\r\nas required; max. 320\u00a0mg daily", "Angina, 80\u2013160\u00a0mg daily in 2\u20133 divided doses; max. 320\u00a0mg daily", "Arrhythmias, 40\u2013240\u00a0mg daily in 2\u20133 divided doses; max. 240\u00a0mg\r\ndaily", "Anxiety symptoms (short-term use), 40\u201380\u00a0mg daily in 1\u20132 divided\r\ndoses", "Name[Trasidrex\u00ae (Goldshield) ] Tablets, red, s/c, co-prenozide\r\n160/0.25 (oxprenolol hydrochloride 160\u00a0mg (m/r), cyclopenthiazide 250\u00a0micrograms), net price\r\n28-tab pack = \u00a310.66. \r\n    Label:\r\n    8, 25Dose\u00a0hypertension, 1 tablet daily, increased if necessary to\r\n2 daily as a single dose"], "pregnancy": "Pregnancy\u00a0\n(From 2.4 Beta-adrenoceptor blocking drugs: British National Formulary)\nPregnancy\u00a0Beta-blockers may cause intra-uterine growth restriction, neonatal hypoglycaemia, and bradycardia; the risk is greater in severe hypertension. The use of labetalol in maternal hypertension is not known to be harmful, except possibly in the first trimester. Information on the safety of carvedilol during pregnancy is lacking. If beta-blockers are used close to delivery, infants should be monitored for signs of beta-blockade (and alpha-blockade with labetalol or carvedilol). For the treatment of hypertension in pregnancy, see section 2.5."}, {"indications": "Indications\u00a0see under Dose", "name": "OXPRENOLOL HYDROCHLORIDE", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "2 Cardiovascular system", "2.4 Beta-adrenoceptor blocking drugs"], "cautions": "Cautions\u00a0see under Propranolol Hydrochloride", "side-effects": "Side-effects\u00a0see under Propranolol Hydrochloride", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/2507.htm", "doses": ["Hypertension, 80\u2013160\u00a0mg daily in 2\u20133 divided doses, increased\r\nas required; max. 320\u00a0mg daily", "Angina, 80\u2013160\u00a0mg daily in 2\u20133 divided doses; max. 320\u00a0mg daily", "Arrhythmias, 40\u2013240\u00a0mg daily in 2\u20133 divided doses; max. 240\u00a0mg\r\ndaily", "Anxiety symptoms (short-term use), 40\u201380\u00a0mg daily in 1\u20132 divided\r\ndoses"], "pregnancy": "Pregnancy\u00a0\n(From 2.4 Beta-adrenoceptor blocking drugs: British National Formulary)\nPregnancy\u00a0Beta-blockers may cause intra-uterine growth restriction, neonatal hypoglycaemia, and bradycardia; the risk is greater in severe hypertension. The use of labetalol in maternal hypertension is not known to be harmful, except possibly in the first trimester. Information on the safety of carvedilol during pregnancy is lacking. If beta-blockers are used close to delivery, infants should be monitored for signs of beta-blockade (and alpha-blockade with labetalol or carvedilol). For the treatment of hypertension in pregnancy, see section 2.5."}]